Please assess the completion status of the following clinical trial:

Trial Title: Immunogenicity and Safety of an Inactivated Non-adjuvanted A(H1N1)v Influenza Vaccine in Pregnant Women

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years to 45 years~* Pregnancy between 22 and 32 weeks of gestation~* Provides written informed consent~* Covered by French Social Security~Exclusion Criteria:~* Allergy to eggs or other components in the vaccine~* History of severe reactions following previous influenza vaccines~* H1N1 influenza (virologically documented) during the last 6 months~* Febrile episode within one week prior to vaccination~* Known HIV, HBV, HCV infection~* Multiple sclerosis~* History of Guillain-Barré syndrome~* Organ transplant recipient~* Neoplastic disease in the past 3 years~* Other vaccine within 3 weeks prior to study entry or planned within the month following the last injection~* Systemic corticosteroids,immunotherapy,chemotherapy~* Anticoagulant treatment~* Immunoglobulin or blood transfusion within the 3 months prior to enrollment in this study~* History of cardiac disease~* Chronic liver disease~* Diabetes before pregnancy~* History of premature delivery~* History of eclampsia~* Fetal morphologic abnormalities

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- vaccine (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).